About the Editors

Editor-in-Chief

Robert D. Steiner, MD
University of Wisconsin School of Medicine and Public Health
ORCID: 0000-0003-4177-4590

Robert D. Steiner, MD, FAAP, FACMG served as Deputy Editor since 2011 and a section editor since 2006. He is Professor (Clinical) of Pediatrics at the University of Wisconsin (UW) School of Medicine and Public Health, Chief Medical Officer for PreventionGenetics, and geneticist and Medical Director at Marshfield Clinic Health System. After obtaining his MD from UW, he completed a residency in pediatrics at The University of Cincinnati/Cincinnati Children’s Hospital and Medical Center.  Following residency, Dr. Steiner trained in medical genetics at The University of Washington/Seattle Children’s Hospital and Regional Medical Center. He is board certified in Pediatrics, Clinical Genetics, and Clinical Biochemical Genetics.

Steiner’s previous academic positions included Executive Director of the Marshfield Clinic Research Institute and Chief Science Officer at Marshfield Clinic, as well as Executive Associate Director of the UW Institute for Clinical and Translational Research.  For most of his career, he was a faculty member at Oregon Health & Science University (OHSU), ultimately named Credit Unions for Kids Professor of Pediatric Research, Professor of Pediatrics and Molecular & Medical Genetics, and (tenured) Vice Chair for Research in Pediatrics. Dr. Steiner is an active clinician with specific interests in inherited metabolic diseases, metabolic bone diseases, laboratory testing, and newborn screening. In addition, he is an accomplished researcher, having served as the Principal Investigator for more than a dozen clinical trials and research studies on Smith-Lemli-Opitz Syndrome (SLOS), Osteogenesis Imperfecta, Phenylketonuria, Lysosomal Storage Diseases, and others. Steiner has authored or co-authored over 150 peer-reviewed original research articles as well as more than 80 reviews, book chapters, and letters. He’s also been a longtime reviewer and award-winning editor for a number of journals.

Dr. Steiner is a member of several professional societies, including the American Society of Human Genetics, American College of Medical Genetics and Genomics (ACMG), Society for Inherited Metabolic Disorders, and the Society for the Study of Inborn Errors of Metabolism. He has had numerous appointments on national committees and advisory boards including as a member and treasurer of the ACMG Board of Directors and of the Health Care System Research Network Board of Governors, the Institute of Medicine advisory panel on accelerating rare disease research, serving as Chair of the ACMG working group on Pompe disease, as a Standing and Steering Committee member of the Newborn Screening Translational Research Network, as an NIH Study Section ad hoc member, and as a member of the ACMG Therapeutics Committee. He was a member of the expert panel convened in 2005 by the US Health and Human Services Health Research Services Agency that reviewed the status of newborn screening in the US and recommended expansion of the program to the US Secretary of Health and Human Services. Dr. Steiner's current potential conflicts of interest are listed here.

Deputy Editor

David T. Miller, MD, PhD
Harvard Medical School, Boston Children's Hospital
ORCID: 0000-0003-1060-1945
Potential conflicts: Vertex Pharmaceuticals (Spouse Salary), Prevention Genetics (Honoraria)

David T. Miller, MD, PhD, FAAP, FACMG served as section editor since 2018. He is Associate Professor of Pediatrics at Harvard Medical School where he is also Co-Director of the Advanced Integrated Science Course in Human Genetics. He is a practicing Medical Geneticist at Boston Children’s Hospital, and Associate Molecular Pathologist at Brigham and Women’s Hospital. After receiving his MD and PhD from Washington University School of Medicine in St. Louis, he completed a residency in pediatrics at Yale-New Haven Hospital, and residency/fellowship in medical genetics and clinical molecular genetics at Harvard Medical School. He is board-certified in Clinical Genetics and Clinical Molecular Genetics.

Dr. Miller is an active clinician and clinical researcher with specific interests in Neurofibromatosis, neurodevelopmental disorders, and clinical genetic test implementation and utility, particularly for chromosomal microarray and exome sequencing. He directs the Neurofibromatosis Research Initiative at Boston Children’s Hospital. Dr. Miller is a member of several professional societies, including the American College of Medical Genetics and Genomics (ACMG), American Society of Human Genetics (ASHG), American Academy of Pediatrics (AAP), and American Medical Association (AMA). He has led or served on several national committees and advisory boards focused on best practices for clinical genetics and genetic testing, including: Chair of ACMG’s Professional Practice and Guidelines Committee; Co-Chair of ACMG’s Secondary Findings Maintenance Working Group; Member of ACMG’s Evidence-Based Medicine Working Group; Steering Committee Member for the International Standards for Cytogenomic Arrays Consortium; and Medical Genetics Committee Member for SPARK, a project of the Simons Foundation Autism Research Initiative (SFARI).

Editors

Biochemical Genetics

V. Reid Sutton, MD
Baylor College of Medicine, Texas Children's Hospital
ORCID: 0000-0002-6450-8554
Potential conflicts: Ultragenyx (Grant), Mereo Biopharma (Grant), Chiesi (Grant), PTC Therapeutics (Consultant), CoA Therapeutics (Consultant), BioMarin (Consultant)

Biomedical Informatics

Peter Tarczy-Hornoch, MD
University of Washington
ORCID: 0000-0003-1047-179X

Cancer Genetics

Douglas R. Stewart, MD
National Cancer Institute
ORCID: 0000-0001-8193-1488
Potential conflicts: Genome Medical (Clinical Consultant)

Ephrat Levy-Lahad, MD
Hebrew University of Jerusalem, Shaare Zedek Medical Center
ORCID: 0000-0002-2637-1921
Potential conflicts: Astra Zeneca SAB meeting

Katherine L. Nathanson, MD
Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania   
ORCID: 0000-0002-6740-0901

Clinical Genetics and Genomics

Fowzan S Alkuraya, MD
King Faisal Specialist Hospital and Research Center
ORCID: 0000-0003-4158-341X

Kandamurugu Manickam, MD
The Ohio State University, Nationwide Children's Hospital
ORCID: 0000-0001-6269-7710

Suma Shankar MD, PhD
University of California Davis
ORCID: 0000-0001-7100-5691

David A. Stevenson, MD
Stanford University
ORCID: 0000-0001-8601-0020
Potential conflicts: Soleno (Grant), GLG/Gerson Lehrman Group® (Consultant)

Cytogenetics/Clinical Genetics

Kathleen A, Leppig, MD
Kaiser Permanente of Washington
ORCID: 0000-0002-8678-6221
Potential conflicts: Atlas Genomics (Consultant), Hanoi National Pediatric (Honoraria)

Economics and Precision Medicine

Kathryn A. Phillips, PhD
University of California, San Francisco
ORCID: 0000-0003-0822-4968
Potential conflicts: Illumina Inc (Consultant)

Education

Mira Bjelotomich Irons, MD
American Board of Medical Specialties
ORCID: 0000-0001-7528-5192

Ethical, Legal and Social Issues

Kyle B. Brothers, MD, PhD
University of Louisville School of Medicine
ORCID: 0000-0002-8550-9724

Mildred K. Cho, PhD
Stanford University
ORCID: 0000-0003-1669-3932

Genetic Counseling

Robin L. Bennett, MS, CGC
University of Washington Medical Center
ORCID: 0000-0001-6748-9582
Potential conflicts: Serves on the board for American Society of Human Genetics

Health Services/Implementation Research

Maren T. Scheuner, MD, MPH
UCSF School of Medicine, San Francisco VA Healthcare System
ORCID: 0000-0002-9105-1369

R. Ryanne Wu, MD, MHS
Duke University
ORCID: 0000-0002-7655-3096
Potential conflicts: GlaxoSmithKline (Spouse Salary)

Laboratory Genetics and Genomics

Catherine W. Rehder, PhD, FACMG
Duke University
ORCID:0000-0003-4924-9010
Potential conflicts: Illumina (Consultant)

Karen E. Weck, MD
University of North Carolina - Chapel Hill
ORCID: 0000-0002-8516-333X
Potential conflicts: BlueCross BlueShield NC (Consultant), serves on the board for American Medical Pathology society

Legal

Lynn D. Fleisher, PhD, JD
American College of Medical Genetics and Genomics
ORCID: 0000-0003-2843-9325

Reproductive Genetics

Susan Klugman, MD
Albert Einstein College of Medicine/Montefiore Medical Center
ORCID: 0000-0001-8775-008X
Potential conflicts: Expert Witness legal cases (Salary)

Public Health, Epidemiology & Personalized Medicine

Katrina Goddard, PhD
Kaiser Permanente, Portland, OR
ORCID: 0000-0001-9535-8993
Potential conflicts: Serves on the board for American Society of Human Genetics

Sonja A. Rasmussen, MD, MS
University of Florida College of Medicine & College of Public Health and Health Professions
ORCID: 0000-0002-0574-4928
Potential conflicts: Teva (Consultant), Novartis (Consultant), Jazz Pharmaceuticals (Consultant), Hoffmann-LaRoche (Consultant)

Statistics

Xianyong Yin, PhD
University of Michigan, Anhui Medical University.
ORCID: 0000-0001-6454-2384

Statistical Genetics

Steve J. Schrodi, PhD
University of Wisconsin-Madison, School of Medicine and Public Health
ORCID: 0000-0003-2304-8528

Therapeutics

Dwight D. Koeberl, MD, PhD
Duke University School of Medicine
ORCID: 0000-0003-4513-2464
Potential conflicts: AskBio (Major Stockholder), Pharming (Grant), Takeda (Consultant)

Managing Editor

Jan Higgins, PhD, ELS
American College of Medical Genetics and Genomics

Social Media Manager and Editorial Assistant

Katharine Murphy
American College of Medical Genetics and Genomics

Communications and Public Relations

Kathy Moran, MBA
American College of Medical Genetics and Genomics

News Editor

V. L Dengler

Podcast Producer

Cynthia Graber